Figure: Total R&D/clinical trials pipeline size, by year 2000-2022
They are so many drugs in development that it is extremely challenging to finds the way to one of them, as a patient or as a site, or to secure a high visibility on one of them for a Sponsor. CT-SCOUT™ and ToTem4me facilitate the match between the patients and the studies.
OF STUDIES FAIL TO MEET PATIENT RECRUITMENT DEADLINES
However, millions of patients visit clinical sites every day.
CT-SCOUT™ help investigators identify the ones that could benefit from a clinical study.
OF THE PATIENTS WOULD WELCOME THE OPPORTUNITY TO PARTICIPATE TO A CLINICAL STUDY
Patients have become actors of their treatment conditions. ToTem4me help them identify potential opportunities through clinical studies.
OF THE PATIENTS ARE BEING OFFERED TO PARTICIPATE TO A CLINICAL STUDY
But 80% of patients would accept to participate t a clinical study. CT-SCOUT™ contributes to increase the percentage of patients considered for clinical research.
WEEKS SET-UP TIME
No more than 2 weeks are required to get CT-SCOUT™
or ToTem4me deployed for a clinical study
We have customised digital solutions for the different contributors to the clinical research efforts.
A multi-device application based on a unique algorithmic model to enable all physicians to quickly detect in real-time, the clinical studies running at their sites, for which a patient is potentially eligible according to his/her current health conditions.
A multi-device application based on a unique algorithmic model, to enable patients, with the direct support of an expert-coordinator, to quickly detect the clinical studies running in their neighborhood, for which they are potentially eligible according to their current health conditions and to inform the corresponding physicians of their potential willingness to participate.
The eISF, or electronic Investigator Site File, is the digital version of the paper-based investigator site file (ISF). It enables the collection in digital form of essential documents that demonstrate a clinical trial was conducted in accordance with Good Clinical Practice (GCP) guidelines, as well as regulatory and sponsor requirements.
17-18 Oct 2023 Building on the success of its long-running US-based counterpart, the 6th Annual SCOPE Europe: Summit for Clinical Ops Executives is a two-day executive conference serving clinical innovation leaders, clin ops execs, digital leaders, functional heads, category managers, and those responsible for the planning and management of clinical trials in Europe and the […]
Biopharm International On Sept. 21, 2023, FDA released a new guidance on how the agency plans to utilize alternative tools to remotely evaluate drug manufacturing facilities identified in a marketing application. The application may be a new drug application, an abbreviated new drug application, a biologics license application, or a supplement to any of these […]
Applied Clinical Trials While many US-based biopharma start-ups are interested in conducting clinical trials in Europe, they are often unfamiliar with European legislation and regulations. Some of the biggest misconceptions are around start-up timelines. Typically, the time it takes to go from initial clinical trial application to delivering the first dose to a patient takes […]